69 results
424B5
AMPE
Ampio Pharmaceuticals Inc
25 Jan 24
Prospectus supplement for primary offering
4:18pm
combination was approved by the board of directors of the corporation and authorized at an annual or special meeting of the stockholders
424B5
AMPE
Ampio Pharmaceuticals Inc
24 Jan 24
Prospectus supplement for primary offering
5:16pm
the stockholder became interested, the business combination was approved by the board of directors of the corporation and authorized at an annual or special … meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder
8-K
EX-10.1
AMPE
Ampio Pharmaceuticals Inc
31 Jul 23
Material Modifications to Rights of Security Holders
6:23pm
at an annual or special meeting of stockholders next following such date (the date of such stockholder approval, the “Effective Date”).
SECTION 19
DEFA14A
9xxo220
13 Jul 23
Additional proxy soliciting materials
11:33am
8-K
EX-3.1
b9vrz6bhtr44
9 Nov 22
Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split
4:22pm
8-K
hqtdvikq7p8
14 Oct 22
Ampio Pharmaceuticals Issues Letter to Stockholders
4:15pm
DEFA14A
497q8rr0t824kcb2x
4 Oct 22
Additional proxy soliciting materials
9:07am
8-K
EX-99.1
m1s38lry
4 Oct 22
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings
8:51am
8-K
76ii g02mbpb
4 Oct 22
Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings
8:51am
424B5
v2z2o18ha4xh
14 Dec 21
Prospectus supplement for primary offering
5:06pm
8-K
EX-10.1
w584jqlb5de9i742
29 Nov 21
Departure of Directors or Certain Officers
4:01pm